Method for detecting multiple target nucleic acids using clamping probes and detection probes

By using a probe mixture method, combined with real-time amplification curve and melting curve analysis, the problem of difficulty in detecting multiple target nucleic acids at the same time in the prior art is solved, and multiple analysis and quantification with high sensitivity and high specificity are achieved , improves the accuracy of cancer diagnosis.

CN105765068BActive Publication Date: 2024-11-26PANAGENE INC
View PDF 5 Cites 0 Cited by

Patent Information

Application Number
CN201480061608.3
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Priority Date
2014-06-03
Filing Date
2014-10-14
Publication Date
2024-11-26
Estimated Expiration
2034-10-14

AI Technical Summary

Technical Problem

Existing genetic testing technologies are difficult to detect multiple target nucleic acids with high sensitivity and high specificity at the same time. Especially in cancer diagnosis, mutant cancer cells are small and difficult to detect, and common methods cannot be analyzed and quantified at the same time. .

Method used

Using a probe mixture including detection probe and clamping probe, adjust its binding energy by changing the three-dimensional structure of the probe or increasing the charge, to achieve selective amplification and detection of multiple target nucleic acids, combined with real-time amplification Curve and melt curve analysis to determine genotype.

Benefits of technology

Selective amplification and detection of trace target nucleic acids are achieved, and multiple target nucleic acids can be detected and quantified simultaneously, improving the early detection ability of cancer diagnosis and the accuracy of diagnosis.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0000986645640000141
    Figure BDA0000986645640000141
  • Figure BDA0000986645640000151
    Figure BDA0000986645640000151
  • Figure BDA0000986645640000152
    Figure BDA0000986645640000152
Patent Text Reader

Abstract

The present invention relates to a method for detecting a target nucleic acid using a clamping probe and a detection probe. More specifically, the present invention relates to a method for simultaneously detecting multiple target nucleic acids using a probe mixture for real-time detection of target nucleic acids, and a kit using the method, the probe mixture comprising at least one detection probe and at least one clamping probe for inhibiting the amplification of a wild-type gene or an unwanted gene. By using the method for detecting a target nucleic acid according to the present invention, the amplification of a wild-type gene or an unwanted gene can be inhibited. In addition, by selectively amplifying and selectively detecting a trace amount of a target nucleic acid gene to be detected, the method enables single nucleotide variations and various mutations caused by the loss or insertion of a base or a specific gene sequence to be effectively detected in a sample. In addition, by using a plurality of detection probes and a plurality of amplification inhibition probes, the method enables simultaneous analysis of a real-time amplification curve and a melting curve, which enables not only simultaneous detection and quantification of multiple target nucleic acids, but also determination of genotypes by melting curve analysis. The probe mixture according to the present invention can detect only a target nucleic acid with high sensitivity (0.01%) from a sample mixed with a large amount of unwanted genes, and can therefore be very useful for early diagnosis of traces of targets that require detection.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to a method for detecting a target nucleic acid using a clamping probe and a detection probe. More specifically, the present invention relates to a method for simultaneously detecting a plurality of target nucleic acids using a probe mixture for real-time detection of target nucleic acids, the probe mixture comprising at least one detection probe and at least one clamping probe for inhibiting amplification of a wild-type gene or an unwanted gene, and a kit using the method. Background Art

[0002] Gene is a very important substance that expresses the properties of an organism through transcription and translation and transmits the properties to its offspring. Genes are composed of base sequences with A (adenine), C (cytosine), G (guanine) and T (thymine) as their basic units. The base sequence of a gene determines the properties of an organism. The analysis of the base sequence and nucleotide polymorphism of a gene is very important in studying biological information. For example, nucleotide polymorphism analysis makes it possible to diagnose genetically related diseases based on genetic traits and prescribe personalized medical prescriptions. In addition, the analysis makes it possible to diagnose infectious viruses and distinguish between drug-resistant bacteria. In addition, the analysis can be widely used in various fields such as species differentiation of organisms and forensics.

[0003] In particular, in Korea, cancer has become the number one cause of death since 1983, and in the field of cancer treatment, since genomic abnormalities such as mutations of oncogenes, mutations or abnormalities of tumor suppressor genes, and chromosomal abnormalities have been found to be directly involved in the occurrence of cancer and the determination of drug prognosis, various studies on genomic abnormalities have been underway (Fearson ER et al., Cell., 1990, 61:759; KW Kinzler et al., Cell., 1996, 87:159; Manuel Serrano et al., Cell., 1997, 88:593; Amado RG et al., J. Clin. Oncol., 2008, 26:1626; Raponi M et al., Curr. Opin. Pharmacol., 2008, 8:413; Siena S et al., J. Natl. Cancer Inst., 2009, 101:1308).

[0004] For this reason, clinically significant mutation detection is very important, and therefore various detection methods that vary depending on the purpose of analysis or genotype are being reported (Taylor CF, Taylor GR. Methods Mol. Med., 92:9, 2004). In particular, in somatic mutations, mutant genes exist at a very low frequency of about 0.1 to 100 bases per megabase of wild-type genes depending on the type of tumor. In addition, the number of mutant cancer cells present in the analysis sample is quite small compared to the number of normal cells, and therefore it is difficult to detect mutant cancer cells, and therefore advanced detection techniques are required for detection (Chung et al., Clin Endocrinol., 65:660, 2006; Trovisco et al., J Pathol., 202:247, 2004).

[0005] As mentioned above, typical methods for detecting trace mutations include various analysis methods based on real-time PCR technology, such as an allele-specific PCR method, which specifically amplifies mutants by using mutant-specific primers so as to selectively increase a small amount of mutant genes (Rhodes et al., Diagn molpathol., 6:49, 1997); a scorpion real-time allele-specific PCR method (DxS'scorpions and ARMS) (Market al., Journal of Thoracic Oncology, 4:1466, 2009); a CAST PCR method, which detects amplification products by using allele-specific primer technology and a minor groove binder (MGB)-probe, which does not include a position where a mutation occurs by using a Taqman probe after suppressing the amplification of a wild-type gene and selectively amplifying only a mutant gene (Didelot A et al., Exp Mol. Pathol., 92: 275, 2012); cold PCR method, which increases the sensitivity of mutants by using critical denaturation temperature (Tc) (Zuo et al., Modern Pathol., 22: 1023, 2009), etc. These techniques can be easily and quickly applied to various diagnoses and are good techniques for diagnosing and analyzing mutations in cancer-related genes (Bernard et al., Clinical Chemistry, 48: 1178, 2002).

[0006] However, in the case of the above method, it is difficult to design the experiment due to reasons such as the primers that only the mutants should be designed and the critical denaturation temperature should be accurately maintained. In addition, in the method using allele-specific primers, if a priming error occurs, a false positive result may be obtained. In addition, the problem with the most widely used Taqman and Scorpion probe methods is that these methods cannot use the melting curve analysis of the probe to perform multiple analyses simultaneously, and therefore the number of genes that can be detected in one tube depends on the number of fluorescences that can be detected by the real-time PCR device.

[0007] Recently, various molecular diagnostic techniques have been developed for detecting somatic mutations by real-time PCR techniques. However, these techniques have not made significant progress in terms of practicality, and it is necessary to develop a technique with high sensitivity and specificity that can perform multiple quantitative analyses simultaneously in a short period of time.

[0008] Peptide nucleic acid (PNA) was reported by Nielsen in 1991 as a nucleic acid analog having N-(2-aminoethyl)glycinamide as its backbone (Nielsen PE et al., Science, 254(5037):1497, 1991). The PNA backbone is electrically neutral and therefore has higher sensitivity and selectivity than DNA probes for target nucleic acids having complementary base sequences. In addition, by introducing specific functional groups at the α, γ positions of the backbone or at the linker portion, the physical properties of PNA, such as cell penetration from the target nucleic acid and its melting temperature, can be freely adjusted (Englund EA et al., Angew. Chem. Int. Ed. Engl., 46: 1414, 2007; Stefano Sforza et al., Eur. J. Org. Chem., 16: 2905, 2000; Roberto Corradini et al., Curr. Top. Med. Chem., 11: 1535. 2011). In addition, it also has the advantage of not being decomposed by nucleases and proteases, and is therefore very useful in molecular diagnostic methods using probes (Egholm et al., Nature, 365: 556, 1993; Nielsen et al., Bioconjugate Chem., 5: 3, 1994; Demidov, et al., Biochem. Pharmacol., 48: 1310, 1994). Using these advantages of PNA, PCR clamping technology was developed in 1993 (Henrik Orum et al., Nucleic Acids Res., 21: 5332, 1993). This technology inhibits PCR amplification of genes that should not be amplified by binding PNA probes to genes. When using a PNA probe that complements the wild-type gene, the amplification of the wild-type gene is inhibited during the PCR reaction, thereby enabling it to quickly and accurately detect mutants that exist in trace amounts compared to the wild-type gene.

[0009] Currently, various techniques using the PNA clamping technique are being reported. Hereinafter, the characteristics of a method for selectively amplifying a gene by using the PNA clamping technique will be briefly described.

[0010] The PNA-LNA clamping method (U.S. Patent Publication No. 2013-0005589; Yoshiaki Nagai et al. Cancer Res., 65 (16): 7276, 2005) is a method for selective amplification and selective detection, which is designed so that a PNA clamping probe having a wild-type gene sequence and an LNA taqman probe for detection having a mutant gene sequence competitively hybridize with a target point. However, this method uses a taqman probe method in which a DNA polymerase having 5'→3' exonuclease activity degrades a mutant probe labeled with a fluorescent substance and a quencher to allow fluorescence. Therefore, according to this method, the melting temperature (Tm) value of the probe cannot be analyzed, and it is impossible to detect multiple targets using one fluorescence.

[0011] PNA hybrid probe (PNA as both PCR clamp and sensor probe; U.S. Patent Publication No. 2008-0176226) is a technology designed to enable PNA probes to simultaneously clamp and detect by changing the donor probe in Roche's conventional hybrid probe system to a PNA probe. However, since the technology still has the limitation that it must include an anchor probe, it is difficult to design such a probe, and the use of a long anchor probe makes it impossible to simultaneously detect multiple mutants at adjacent positions. In addition, since the melting temperatures of the PNAs from each of the mutant genotypes are not significantly different from each other, the use of a PNA probe that simultaneously clamps and detects makes it difficult to analyze multiple mutant genotypes within the same codon by melting curve analysis of the PNA probe.

[0012] The PNA clamping and intercalator detection method (Makito Miyake et al., Biochem Biophys Res Commun., 362: 865, 2007) is a method in which only a mutant gene is selectively amplified by clamping the wild-type gene using a PNA probe, and then the amplification product is detected by using an intercalator. This method cannot perform multiple detections at the same time, and in the case where the wild-type gene is not completely clamped, false positive results may occur, and therefore it is difficult to analyze these results.

[0013] The method using PNA and unlabeled DNA probe (Ji Eun Oh et al., J Mol Diagn., 12: 418, 2010) is a method in which the melting curve of the unlabeled DNA probe from the mutant gene is analyzed by using an intercalator after clamping the wild-type gene with the PNA probe. The problem with this method is that it is not possible to perform specific real-time amplification curve analysis and multiple detections simultaneously, and it has low sensitivity. Summary of the invention

[0014] Technical issues

[0015] As a result of conducting research to solve the above problem, the inventor of the present invention finds that by using a clamping probe and a mixture of the fluorescence detection probe including a fluorescent substance and a quencher to selectively detect a desired gene with high sensitivity, it is possible to detect target nucleic acid in real time and easily detect adjacent mutations. In addition, the inventor finds that by increasing the difference in the melting temperature of the probe between a wild-type gene and a target nucleic acid gene, it is possible to detect multiple target nucleic acids simultaneously and quantify the multiple target nucleic acids, and determine its genotype by amplification curve and melting curve analysis. Therefore, the inventor has completed the present invention.

[0016] In addition, the inventors found that by using a probe mixture including a detection probe and a clamping probe to detect the target nucleic acid in real time, each of the detection probe and the clamping probe is structurally modified by changing the three-dimensional structure or increasing the charge, etc., the binding energy of heterodimers and self-dimers is reduced and the specificity for single nucleotide variations is increased, which makes it easy to selectively amplify and detect trace amounts of target nucleic acid genes.

[0017] The probe mixture system of the present invention can be used in various molecular diagnostic techniques such as molecular diagnosis, prenatal diagnosis, early diagnosis, cancer diagnosis, genetic-related diagnosis, diagnosis of genetic traits, diagnosis of infectious viruses, identification of drug-resistant bacteria, forensics, identification of species of organisms, etc.

[0018] Solution to the problem

[0019] In order to achieve the above-mentioned objectives, the present invention provides a probe mixture for real-time detection of target nucleic acids, comprising at least one detection probe and at least one clamping probe for inhibiting the amplification of wild-type genes or unwanted genes, a method for using the probe mixture to simultaneously detect multiple target nucleic acids, and a kit for diagnosing molecules using the method.

[0020] The probe mixture of the present invention provides a method for simultaneously detecting multiple target nucleic acids using a clamping probe and at least one detection probe attached with a reporter and a quencher, wherein the clamping probe and the detection probe both competitively hybridize with the same chain, or the probe mixture provides a method for simultaneously detecting multiple target nucleic acids using a clamping probe and at least one detection probe attached with a reporter and a quencher, wherein the clamping probe and the detection probe hybridize with complementary chains.

[0021] Beneficial effects of the present invention

[0022] By using the method for detecting target nucleic acid according to the present invention, the amplification of wild-type genes or unwanted genes can be suppressed. In addition, by selective amplification and selective detection to trace target nucleic acid genes, the method makes it possible to effectively detect single nucleotide variations and sudden changes caused by the loss of base or insertion in the sample. In addition, by using a plurality of detection probes and a plurality of amplification inhibition probes, the method makes it possible to analyze real-time amplification curve and melting curve simultaneously, which makes it possible not only to detect and quantify a plurality of target nucleic acids simultaneously, but also to determine genotype by melting curve analysis. In addition, the method makes it possible to detect a target with high sensitivity, and therefore can be very useful for the early diagnosis of the trace that needs to detect the target. BRIEF DESCRIPTION OF THE DRAWINGS

[0023] Figure 1 is a schematic diagram of the probe mixture. Figure 1 Figure a in Figure 1 is a schematic diagram of a probe mixture including a clamping probe and a detection probe that hybridize competitively on the same strand, and Figure 1 Figure b in is a schematic diagram of a probe hybrid comprising a clamping probe and a detection probe hybridized on complementary strands.

[0024] Figure 2 A graph illustrating the decrease in the melting temperature of a self-dimer of a PNA probe given a three-dimensional structure is shown.

[0025] Figure 3 Shown is a graph illustrating the melting temperatures of heterodimers of a PNA detection probe bound to a clamping probe in an antiparallel orientation and a PNA detection probe bound to a clamping probe in a parallel orientation.

[0026] Figure 4 A graph illustrating the decrease in melting temperature of a heterodimer of a PNA detection probe imparting a three-dimensional structure and a PNA clamping probe imparting a three-dimensional structure is shown.

[0027] Figure 5The graphs show an example of the amplification curve and melting curve of G12A (SEQ ID No. 15), a K-ras gene mutant, using the PNA mixture of the present invention.

[0028] Figure 6 The graphs show an example of the amplification curve and melting curve of G12S (SEQ ID No. 16), a K-ras gene mutant, using the PNA mixture of the present invention.

[0029] Figure 7 The graphs show an example of the amplification curve and melting curve of G12R (SEQ ID No. 17), a K-ras gene mutant, using the PNA mixture of the present invention.

[0030] Figure 8 The graphs show an example of the amplification curve and melting curve of G12C (SEQ ID No. 18), a K-ras gene mutant, using the PNA mixture of the present invention.

[0031] Fig. 9 The graphs show an example of the amplification curve and melting curve of G13D (SEQ ID No. 19), a K-ras gene mutant, using the PNA mixture of the present invention.

[0032] Fig.10 Graphs illustrating amplification curves and melting curves of an internal control (SEQ ID No. 20) using the PNA mix of the present invention are shown.

[0033] Fig.11 A graph showing melting curve signals of probes of SEQ ID Nos. 16, 17 and 18 according to the concentrations of target G12S, G12R and G12C contained in the wild-type gene is shown. This indicates that genotypes can be determined by melting curve analysis of three types of K-ras mutant genes: G12S, G12R, G12C (SEQ ID Nos. 16, 17 and 18) using one fluorescence channel.

[0034] Fig.12 Shown is a graph illustrating an amplification curve of T790M as an EGFR gene mutant using mgb-Taqman probe for detection-PNA probe for clamping.

[0035] Figure 13 shows a diagram illustrating the melting curves of mutant genes that perfectly match the probe for detection, mutant genes that mismatch the probe for detection, and wild-type genes. The sequence of the detection probe in Figure 13 (A) is SEQ ID No. 33, and the mutant gene in the perfect match is G12D. The sequence of the detection probe in Figure 13 (B) is SEQ ID No. 34, and the mutant gene in the perfect match is G12V.

[0036] FIG. 14 shows graphs illustrating changes in detection sensitivity according to changes in the mixing ratio of wild-type genes and mutant genes. FIG. 14(A) is a graph illustrating the sensitivity of mutation detection for a sample containing 1% of mutant genes (G12D, G12A, G12V). FIG. 14(B) is a graph illustrating the sensitivity of mutation detection for a sample containing 0.1% of mutant genes. FIG. 14(C) is a graph illustrating the sensitivity of mutation detection for a sample containing 0.01% of mutant genes.

[0037] Fig. 15 shows a graph of melting curves using a probe having no specific change in structure, which illustrates a graph of melting curves of a probe and a target DNA for detection. The sequence of the detection probe in Fig. 15(A) is SEQ ID No.37, and the sequence of the detection probe in Fig. 15(B) is SEQ ID No.38. DETAILED DESCRIPTION

[0038] Unless otherwise specified, all technical and scientific terms used in this specification have the same meanings as those commonly understood by those of ordinary skill in the art. The nomenclature used in this specification is known and commonly used in the technical field.

[0039] The present invention relates to a method for simultaneously detecting a plurality of target nucleic acids using a clamping probe for suppressing amplification of a wild-type gene or an unwanted gene and a detection probe to which a reporter and a quencher are attached.

[0040] The term "detection probe" in the present invention refers to a probe that can selectively detect a target nucleic acid gene to be detected. The term "clamping probe" refers to a probe that can inhibit the extension of a polymerase between PCR reactions by complementarily binding to a wild-type gene or an unwanted gene. The term "probe mixture" refers to a probe system comprising at least one detection probe and at least one clamping probe.

[0041] The term "target nucleic acid" in the present invention refers to all types of nucleic acids to be detected, and may or may not include mutant genes. The present invention may be characterized in that all types of DNA include genomic DNA, mitochondrial DNA and viral DNA or all types of RNA include mRNA, ribosomal RNA, non-coding RNA, tRNA, viral RNA, etc., but is not limited thereto. It is annealed or hybridized using primers or probes under hybridization, annealing or amplification conditions.

[0042] The term "hybridization" in the present invention refers to the complementary single-stranded nucleic acid that forms a double-stranded nucleic acid. Hybridization occurs when the two nucleic acid strands are in perfect match. Hybridization may also occur even when there are some mismatched bases. The degree of complementarity required for hybridization can be changed according to hybridization conditions such as, in particular, temperature.

[0043] The term "mutation" in the present invention refers to the variation of the base sequence of the wild-type gene, including not only single nucleotide polymorphisms (SNPs), but also variations caused by substitution, loss or insertion of bases. In addition, mutations include somatic mutations and germline mutations that can occur naturally, and also include artificial mutations, etc., without limitation, in which the variation of the base sequence is artificially induced. The term "somatic mutation" in the present invention refers to a gene mutation that occurs in somatic cells. Somatic mutations are known to be the main cause of tumorigenesis caused by abnormalities in signal transduction processes, etc. Examples of significant "somatic mutations" include various cancer-related genes such as KRAS, BRAF, EGFR, JAK2, HER2, BCL-ABL, NRAS, HRAS, IDH1, IDH2, C-KIT, TP53, EGFR, PIK3CA, etc. In the present invention, the inventors confirmed that the present invention works from the example of mutations for the somatic gene K-ras (V-Ki-ras2Kirsten rat sarcoma viral oncogene homologous), and thus completed the present invention.

[0044] In the present invention, the detection probe and the clamping probe can be any nucleic acid or nucleic acid analog selected from the group consisting of oligonucleotides, peptide nucleic acids (PNA) and locked nucleic acids (LNA) that complementarily bind to the target nucleic acid. Generally speaking, the polymerase of PCR has nuclease activity, which may cause damage to the probe. Therefore, it is recommended to use synthetic nucleic acids such as PNA that are stable to nucleases. In addition, since the detection probe plays a role in selectively detecting the target nucleic acid gene, probes for detecting nucleic acids that are well known in the relevant art can be used. In order to confirm whether the target nucleic acid can be detected even when the detection probe of the present invention is a nucleic acid analog other than PNA, analysis was performed using MGB-taqman as the detection probe. As a result, it was confirmed from the real-time amplification curve analysis that the system of the MGB-taqman probe for detecting mutations and the PNA probe for clamping the wild-type gene operate on different chains ( Fig.12 ).

[0045] In the present invention, PNA probes are preferably used. PNA probes are artificially synthesized DNA, and can specifically bind to target DNA or RNA. In addition, since PNA probes are stable against nucleases, they allow probe-based melting curve analysis. In addition, PNA probes have the characteristic of inhibiting the progress of polymerase after binding to DNA. Therefore, in the present invention, PNA probes designed to fully hybridize with wild-type genes are used as PNA clamping probes, and PNA detection probes for simultaneously detecting multiple target nucleic acids are designed to fully hybridize with target nucleic acid genes.

[0046] In addition, according to the present invention, the three-dimensional structure of the clamping probe and the detection probe can be modified by attaching a specific group such as a side chain of a natural amino acid or a synthetic amino acid at the N-terminal, C-terminal or α, β, γ, joint position of the probe (synthetic nucleic acid) backbone. The amino acid may have an electric charge or may not have an electric charge, or may have a negative charge or a positive charge, but is not limited thereto. Any method known in the relevant art for changing the three-dimensional structure of the probe or giving an electric charge can be used.

[0047] The detection probe in the present invention can have a reporter and a quencher capable of quenching the fluorescence of the reporter attached to both ends of the reporter, and can include an intercalating fluorescent substance.

[0048] The term "reporter" refers to a substance that absorbs and emits light of a specific wavelength to emit fluorescence and labels the probe to identify whether the target nucleic acid and the probe are hybridized. The reporter can be at least one selected from the group consisting of fluorescein, fluorescein chlorotriazinyl, rhodamine green, rhodamine red, tetramethylrhodamine, FITC, Oregon Green, Alexa Fluor, FAM, JOE, ROX, HEX, Texas Red, TET, TRITC, TAMRA, cyanine-based dyes, and thiadicarbocyanine dyes.

[0049] In addition, the term "quencher" refers to a substance that absorbs light generated by a reporter to reduce the intensity of fluorescence. The quencher can be at least one selected from the group consisting of Dabcyl, TAMRA, Eclipse, DDQ, QSY, Blackberry Quencher, Black Hole Quencher, Qxl, Iowa Black FQ, Iowa Black RQ, IRDye QC-1, but is not limited thereto. The quencher reduces the intensity of fluorescence to different degrees depending on its type, and thus can be used to take this matter into consideration.

[0050] In the present invention, a plurality of target nucleic acids are detected simultaneously by using a probe cocktail for real-time detection of target nucleic acids, the probe cocktail comprising at least one detection probe and at least one clamping probe for suppressing amplification of a wild-type gene or an unwanted gene.

[0051] The method for simultaneously detecting multiple target nucleic acids using the probe mixture of the present invention is characterized in that one or at least one clamping probe that inhibits the extension of a polymerase is used by complementarily binding to a wild-type gene or an unwanted gene to selectively amplify the target nucleic acid gene to be detected, and one or at least one detection probe for specifically detecting the target nucleic acid is used to detect the presence or concentration of multiple target nucleic acids. Using the probe mixture to detect the target nucleic acid enables simultaneous analysis of real-time amplification curves and melting curves.

[0052] like Figure 1 As exemplified in the above, the clamping probe and the detection probe of the present invention are bound to the same strand of the target DNA ( Figure 1 a) in Figure 2, or the clamp probe and the detection probe are hybridized with the complementary strand ( Figure 1b) hybridization, thus blocking the wild-type gene and detecting the target nucleic acid gene at the same time. That is to say, if the clamping probe hybridizes with the wild-type gene in a perfect match, the amplification of the wild-type gene can be suppressed, which enables it to selectively amplify and detect the trace of the target nucleic acid gene. In addition, by using at least one detection probe, multiple target nucleic acids can be detected simultaneously.

[0053] The process of amplifying the target DNA using a probe mixture will be explained in more detail below. In the annealing step, each of the clamping probe and the detection probe is annealed to the same chain or different complementary chains. The detection probe with a reporter and a quencher specifically binds to the target nucleic acid to be detected, thereby emitting an amplification curve signal (fluorescence). In the subsequent extension step, the clamping probe still hybridizes with the wild-type gene or the unwanted gene, and thus suppresses the amplification of the wild-type gene or the unwanted gene. The detection probe is separated from the target nucleic acid to allow amplification to proceed, because the detection probe is designed to have a melting temperature lower than the temperature of the extension of the target nucleic acid.

[0054] Amplification process enables real-time analysis of amplification curves. In addition, melting curve analysis is possible by using the amplification product generated by amplification process. In the melting curve analysis step, at low temperatures, the detection probe hybridizes with the target nucleic acid gene, thus emitting a fluorescent signal, but as the temperature rises, the detection probe separates from the target nucleic acid and therefore quenches the fluorescence.

[0055] In addition, among the clamping probe and the detection probe in the probe mixture of the present invention, these probes designed to operate from different directions of the target DNA chain are likely to form heterodimers. Therefore, in order to reduce the heterodimer binding energy of clamping probe or detection probe, it is preferred that the detection probe or clamping probe is structurally modified by changing the three-dimensional structure of the detection probe or the clamping probe, giving electric charge, etc. Through this change, the binding energy of the heterodimer or self-dimer of the probe is reduced, which makes it easy to adjust the melting temperature of the probe. Therefore, the detection system has been completed.

[0056] In an embodiment of the present invention, in order to confirm the difference in melting temperature, a PNA probe is synthesized by introducing negatively charged L-glutamic acid or D-glutamic acid, uncharged L-alanine or D-alanine, or positively charged L-lysine or D-lysine at the γ position of PNA and introducing a side chain of L-lysine or L-glutamic acid at the linker position (Table 1).

[0057] According to the results of analyzing the characteristics of each modified PNA probe by using a melting curve analysis method, it was found that in the PAN probes of SEQ ID Nos. 4 to 7 or 11 to 14 having side chains of glutamic acid and lysine attached at the γ position of the PNA backbone, the melting temperature of the self-dimer was lower than that of the PNA probe of SEQ ID No. 1 ( Figure 2 ). In addition, from the comparison between the detection PNA probes of SEQ ID Nos. 1 to 7 that formed heterodimers with the clamping probe of SEQ ID No. 23 and bound to the clamping probe in the antiparallel direction and the detection PNA probes of SEQ ID Nos. 8 to 16 that bound to the clamping probe in the parallel direction, it was found that heterodimers were formed in the case of antiparallel binding, but not in the case of parallel binding ( Figure 3 ).

[0058] In addition, from the comparison of the clamp probe of SEQ ID No. 21 attached to the detection PNA probes of SEQ ID Nos. 15 to 19 and the clamp probe of SEQ ID No. 22 with L-glutamic acid in terms of heterodimer formation, it was found that when the clamp probe of SEQ ID No. 22 with L-glutamic acid attached was used, the melting temperature of the heterodimer was sharply decreased compared with the case where the clamp probe of SEQ ID No. 21 without modification was used ( Figure 4 ).

[0059] When compared with the PNA probe of SEQ ID No. 1, the PNA probes of SEQ ID Nos. 3, 5 and 7, which were structurally modified (in terms of three-dimensional structure and charge) by attaching D-glutamic acid at the γ position of the PNA backbone, showed a large increase in the difference (ΔTm) in the melting temperature between the target DNA and the single nucleotide mismatch DNA (Table 4). In addition, it was confirmed that the PNA probe having a modified structure of the present invention has specificity for the increase of single nucleotide variation, thereby achieving the difference in melting temperature at 20°C between the wild-type gene and the target nucleic acid gene, which makes it possible to reduce nonspecific binding in real-time amplification curves and problems that may occur in melting curve analysis.

[0060] Generally speaking, in order to detect multiple target nucleic acids simultaneously, the conventional method for using real-time PCR to analyze amplification curve uses fluorescent substances to detect the target nucleic acids in the sample. Therefore, the problem with these methods is that, in order to detect at least two target nucleic acids, probes with fluorescent substances as many as the number of targets are needed, and therefore these methods have limitations in multiple detection. However, the method for detecting multiple target nucleic acids simultaneously of the present invention can carry out amplification curve analysis and melting curve analysis simultaneously by using a probe mixture, and therefore can detect multiple targets by using a fluorescent substance.

[0061] In addition, the method for using probe mixture of the present invention to detect multiple target nucleic acids simultaneously is not limited to the simultaneous analysis of amplification curve and melting curve. The method also enables the individual analysis or sequential analysis of amplification curve and melting curve. If necessary, the method also enables the detection of target nucleic acid by only performing amplification curve analysis or melting curve analysis. Especially, according to the method of the present invention, in the case of not needing quantitative analysis, by only performing curve analysis separately and not performing amplification curve analysis, it is possible to determine the existence or genotype of target nucleic acid.

[0062] Specifically, the method of the present invention for simultaneously detecting multiple target nucleic acids includes the following steps: (a) mixing a probe mixture including a clamping probe and a detection probe and a primer with a test sample including the target nucleic acid, and hybridizing the mixture to obtain a real-time amplification curve; (b) obtaining a melting curve of the detection probe from the amplification product and the detection probe complex by changing the temperature after the amplification process; and (c) analyzing the real-time amplification curve and melting curve obtained separately, sequentially or simultaneously.

[0063] The clamping probe and the detection probe in step (a) can be adjusted in various ways according to the number of target nucleic acids to be detected. In order to reduce the deviation of the melting temperature according to the concentration of the amplified product in the step of obtaining the melting curve, at least 5 PCR cycles can be added before the step of obtaining the melting curve, in addition to the step of obtaining the real-time amplification curve. Preferably, 5 to 20 cycles can be added.

[0064] In addition, as a detection method of the present invention, a method for simultaneously detecting multiple target nucleic acids can be used, which method includes the following steps: (a) mixing a probe mixture including a clamping probe and a detection probe and a primer with a test sample including a target nucleic acid, and hybridizing the mixture to obtain a real-time amplification curve; and (b) analyzing the obtained real-time amplification curve, or the method includes the following steps: (a) mixing a probe mixture including a clamping probe and a detection probe and a primer with a test sample including a target nucleic acid, and hybridizing the mixture; (b) melting the hybridized product by changing the temperature to obtain a melting curve; and (c) analyzing the obtained melting curve.

[0065] The step of obtaining amplification curve or melting curve in the present invention is performed by real-time PCR (polymerase chain reaction), and the amplification curve analysis is characterized in that Ct (cycle threshold) is measured and Ct is analyzed. If there is a target nucleic acid in the sample or a large amount of target nucleic acid is contained in the sample, the number of cycles required to reach the threshold value is reduced, thus resulting in a low Ct value. Therefore, this analysis enables the presence of the target nucleic acid to be confirmed, and the amount of the initial target nucleic acid can be detected.

[0066] In addition, generally speaking, the melting curve analysis is performed last after the real-time PCR process is completed. In this analysis, after the temperature of the sample is lowered to about 30-55°C, the amplitude of the fluorescence signal is measured while the temperature is raised to 95°C at 0.5-1°C per second. When the temperature rises, the detection probe and the target nucleic acid (a chain of the target nucleic acid that can complementarily bind to the detection probe) separate from each other, and then the fluorescence is quenched, which leads to a sharp decline in the fluorescence signal. Therefore, the presence of the target nucleic acid can be determined by the melting peak.

[0067] The method for simultaneously detecting a plurality of target nucleic acids of the present invention is characterized by detecting target nucleic acids contained in an amount of 0.01% or 0.1% to 100% in a nucleic acid sample of 10 ng or less.

[0068] The term "sample" in the present invention encompasses various samples. Preferably, the method of the present invention is used to analyze biological samples. Biological samples of plant, animal, human, fungus, bacteria and virus origins can be analyzed. In the case of analyzing samples of animal or human origin, samples can be derived from specific tissues or organs. Representative examples of tissues include connective tissue, skin tissue, muscle tissue and nerve tissue. Representative examples of organs include eyes, brain, lung, liver, spleen, bone marrow, thymus, heart, lymph, blood, bone, cartilage, pancreas, kidney, gallbladder, stomach, small intestine, testicle, ovary, uterus, rectum, nervous system, gland and internal blood vessels. The biological sample to be analyzed includes any cell, tissue or liquid of biological origin or any medium that can be well analyzed by the present invention, including samples obtained from food produced to be consumed by humans, animals or humans and animals. In addition, biological samples to be analyzed include, but are not limited to, body fluid samples, including blood, serum, plasma, lymph, milk, urine, human feces, ocular fluid, saliva, semen, brain extracts (e.g., brain fragments), cerebrospinal fluid, and extracts from appendix, spleen, and tonsil tissue.

[0069] The target nucleic acid of the sample is DNA or RNA, and the molecule can be in the form of double-stranded or single-stranded. In the case where the nucleic acid as the initial material is double-stranded, it is preferred that the double-stranded is made into a single-stranded or partially single-stranded form. Known methods for chain separation include heat treatment, alkali treatment, formamide treatment, urea treatment and glyoxal treatment, enzyme methods (e.g., gyrase action) and binding proteins, but are not limited to this. For example, chain separation can be achieved by heat treatment to 80-105°C. Joseph Sambrook et al,, Molecular Cloning, 2001 discloses the general method of the above-mentioned treatment.

[0070] In an embodiment of the present invention, the K-ras (V-Ki-ras2Kirsten rat sarcoma viral proto-oncogene homolog) gene, which is a representative somatic gene that frequently mutates, was used as a target nucleic acid to be subjected to simultaneous detection of multiple target nucleic acids to perform the experiment. In Table 5, the genes were separated from each cell line, and the samples were prepared to include 100%, 10%, 1% or 0% of each mutant gene in the wild-type gene (Table 6).

[0071] In order to confirm whether multiple detection of 5 types of mutant genes included in the wild-type gene can be performed simultaneously, SEQ ID Nos. 15 to 19 in Table 1 were used as PNA detection probes, SEQ ID No. 22 as a PNA clamping probe, and SEQ ID No. 20 as an internal control (complementarily binding to the wild-type gene). A reaction mixture solution of PNA probes and PCR primers was prepared by the method of Example 4-1, and real-time PCR reaction analysis and melting curve analysis were performed for simultaneous analysis of multiple genotypes.

[0072] As a result of analyzing the real-time amplification curve and melting curve of the wild-type gene and the K-ras mutant gene according to the method of the present invention, Figures 5 to 11 As shown in , it was found that not only could multiple K-ras mutant genes G12A, G12S, G12R, G12C and G13D, which are 1% contained in the wild-type gene, be detected simultaneously, but also the mutant genotypes could be identified and quantified.

[0073] In addition, as a Figures 5 to 10 The results of analyzing the amplification curves in the present invention showed that the amplification of the wild-type gene was 100% inhibited by the PNA clamp probe of the present invention. In addition, it was confirmed that by using the difference in melting temperature among the mutation detection probes, various mutations can be detected simultaneously even with a small number of fluorescent channels. Fig.11 and Table 8).

[0074] That is, the method for simultaneously detecting multiple target nucleic acids of the present invention structurally modifies the clamping probe and the detection probe to reduce the melting temperature of the self-dimer or heterodimer between the probes and increase the specificity for single nucleotide variations, thereby making it possible to simultaneously detect the traces of different multiple target nucleic acids and determine and quantify the genotype.

[0075] According to another aspect, the present invention relates to a kit for simultaneously detecting multiple target nucleic acids, the kit comprising a probe cocktail including a clamping probe and a detection probe, and using the method for simultaneously detecting multiple target nucleic acids of the present invention.

[0076] According to the present invention, the kit can simultaneously detect various target nucleic acids contained in a sample in an amount of 1 to 100%, and can be used to analyze the quantity or genotype of the target nucleic acids.

[0077] The kit of the present invention may optionally include reagents required for performing target amplification PCR (e.g., PCR), such as buffer, DNA polymerase cofactor and deoxyribose-5-phosphate. In addition, the kit of the present invention may optionally include various polynucleotide molecules, reverse transcriptase, various buffers and reagents, and antibodies that inhibit DNA polymerase activity.

[0078] In addition, those skilled in the art who are aware of the disclosure in this specification can easily determine the optimal amounts of reagents of the kit in a specific reaction.Generally, the kit of the present invention is manufactured as separate packages or compartments including the above-mentioned components.

[0079] Example

[0080] Hereinafter, the present invention will be explained in more detail with reference to examples. These examples are only used to illustrate the present invention, and it is obvious to those skilled in the art that the scope of the present invention is not to be construed as being limited by these examples.

[0081] Probe hybrid system comprising a clamping probe hybridized to a complementary strand and a detection probe

[0082] [Example 1]

[0083] Synthesis of PNA probes and target DNA oligomers for mutation detection

[0084] 1-1: Generation of PNA probes

[0085] As can be seen in Table 1, in order to demonstrate the feasibility of a method for detecting mutations using a PNA hybrid comprising a detection probe and a clamping probe that are structurally modified by changing the three-dimensional structure or imparting a charge, a PNA probe having a negatively charged L-glutamic acid or D-glutamic acid, an uncharged L-alanine or D-alanine, or a positively charged L-lysine or D-lysine attached at the γ position of the PNA probe backbone was synthesized.

[0086] [Table 1]

[0087] Sequences of PNA probes used in the present invention

[0088]

[0089]

[0090] (The numbers of the PNA sequences in Table 1 indicate the modification of a portion of the PNA sequence to L-glutamine, D-glutamine, L-alanine, D-alanine, L-lysine, or D-lysine. For more details, see Table 2.)

[0091] [Table 2]

[0092] Modification of PNA sequences

[0093]

[0094] According to the method disclosed in Korean Patent No. 464261, the PNA probe is synthesized by performing solid phase synthesis from a PNA monomer protected with a benzothiazole sulfonyl group (Bts) and a functionalized resin (Lee et al., Org. Lett., 9: 3291, 2007). In addition, PNA can be synthesized by a known 9-fluorenylmethoxycarbonyl (Fmoc) or t-Boc (t-tert-butyloxycarbonyl) synthesis method (Kim L. et al., J. Org. Chem., 59: 5767, 1994; Stephen A. et al., Tetrahedron, 51: 6179, 1995). According to a method widely known in the related art, a reporter substance and a quencher substance are attached to the PNA probe.

[0095] The PNA probes of SEQ ID Nos.: 1 to 7 and 15 to 19 are detection probes and are designed to detect mutations. The PNA probes of SEQ ID Nos.: 8 to 14 were generated as parallel binding detection probes.

[0096] 1-2: Generation of DNA oligomers

[0097] In order to analyze the characteristics of the PNA probes generated in Table 1 above, DNA oligomers bound to PNA probes synthesized by Bioneer Co. (Korea) were used (Table 3).

[0098] [Table 3]

[0099] DNA oligomer sequences for characterization of PNA probes

[0100] SEQ ID No. name Sequence (5'→3') 24 >5-up 0C GTAGTTGGAGCTGCTGGCGTAGGCAAG 25 >1-up wild type <![CDATA[GTAGTTGGAGCTG G TGGCGTAGGCAAG]]>

[0101] The PNA probes corresponding to SEQ ID Nos.: 1 to 14 in Table 1 completely hybridized with SEQ ID No. 24 in Table 3 (>5-up 0C), but not completely hybridized with SEQ ID No. 25 (1-up wild type) (single nucleotide mismatch).

[0102] [Example 2]

[0103] Analysis of PNA probe characteristics using melting curve analysis

[0104] In order to analyze the formation and specificity of the self-dimer and heterodimer of the PNA probe produced in Example 1-1, the 0.5 μM PNA probe in Table 1 above, the 0.5 μM DNA oligomer in Table 3, and the PCR amplification solution (Enzynomics, South Korea) were mixed. The mixture was subjected to a denaturation step at 95°C for 5 minutes in a real-time PCR machine (CFX96TM Real-Time PCR System, Bio-Rad, USA). Then, the mixture was cooled to 30°C and then hybridized for 5 minutes. After this, a melting curve analysis was performed by measuring fluorescence while increasing the temperature from 30°C to 95°C at 0.5°C.

[0105] As a result, it was found that the probes of SEQ ID Nos. 4, 5, 6 and 7 to which glutamic acid or lysine was attached and the probes of SEQ ID Nos. 11, 12, 13 and 14 having glutamic acid or lysine bound in a parallel direction showed a decrease in the melting temperature of the self-dimer when compared with the PNA probe of SEQ ID No. 1. Figure 2 The comparison results of SEQ ID Nos. 1 and 4 are shown in FIG.

[0106] From the comparison between the detection PNA probes of SEQ ID Nos. 1 to 7 that form heterodimers with the clamping probe of SEQ ID No. 23 and bind to the clamping probe in the antiparallel direction and the detection PNA probes of SEQ ID Nos. 8 to 16 that bind in the parallel direction, it was found that heterodimers are formed in the case of antiparallel binding, but not in the case of parallel binding. As an example, in Figure 3 The comparison results of the formation of heterodimers between SEQ ID Nos. 1 and 23 and SEQ ID Nos. 8 and 23 are shown in FIG.

[0107] From the comparison between the clamp probe of SEQ ID No. 21 which formed a heterodimer with the detection PNA probes of SEQ ID Nos. 15 to 19 and the clamp probe of SEQ ID No. 22 to which L-glutamic acid was attached, it was found that when the clamp probe of SEQ ID No. 22 to which L-glutamic acid was attached was used, the melting temperature of the heterodimer was sharply decreased compared with the case where the unmodified clamp probe of SEQ ID No. 21 was used. As an example, in Figure 4] The results of comparison of heterodimer formation between SEQ ID Nos. 15 and 21 and SEQ ID Nos. 15 and 22 are shown in FIG. In addition, it was confirmed that when the clamp probe of SEQ ID No. 22 was used, the melting temperature of the heterodimer was decreased by about 10°C (Tm: 75.5°C → 65.5°C) compared to the case where the clamp probe of SEQ ID No. 21 was used.

[0108] [Table 4]

[0109] Comparison of the melting temperatures of PNA probes given a three-dimensional structure and single nucleotide mismatch sequences.

[0110]

[0111] In addition, it was found that the PNA probes of SEQ ID Nos. 3, 5 and 7, which were structurally modified (in terms of three-dimensional structure and charge) by attaching D-glutamic acid at the γ position of the PNA backbone, showed a sharp increase in the difference (ΔTm) in their melting temperatures between the target DNA and the DNA having a single nucleotide showing a mismatch when compared with the PNA probe of SEQ ID No. 1 (Table 4). In this way, the PNA probes of the present invention having a modified structure have increased specificity for single nucleotide variations, so that the difference in melting temperature between the wild-type gene and the mutant gene is at least 20°C, which makes it possible to solve the problem of non-specific signals appearing in the analysis of melting curves and amplification curves.

[0112] [Example 3]

[0113] Generation of target nucleic acids and primers for simultaneous detection of multiple somatic mutations

[0114] The experiment was conducted using the K-ras (V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog) gene, which is a representative somatic gene that frequently mutates, as a target nucleic acid for simultaneous detection of multiple somatic mutations. A wild-type cell line (HeLa) of wild-type K-ras codons 12 and 13 and five mutant cell lines (SW-1116, A549, SW48, MIA PaCa2, LoVo) were obtained from a Korean cell line library (Table 5).

[0115] [Table 5]

[0116] Location of K-ras mutations and mutant cell lines

[0117]

[0118] The obtained cell line was cultured in an incubator at 37°C and 5% carbon dioxide (CO2) using a medium obtained by adding 10% heat-inactivated fetal bovine serum (FBS, Hyclone Corporation, Thermo Scientific, USA) and 1× penicillin-streptomycin (Welgene, Korea) to RPMI1640 (fetal bovine serum, Thermo Scientific, USA). The cell line was cultured using Labopass based on the instructions provided with the kit. TM The target nucleic acid was obtained by extracting DNA from the cultured cell line using a tissue mini kit (Cosmogenetech, Korea). The samples were prepared so that the wild-type gene obtained above included 100%, 10%, 1% or 0% of each mutant gene (Table 6).

[0119] [Table 6]

[0120] Amount of target nucleic acid used in the reaction

[0121] wild-type gDNA Mutant gDNA Mutant 100% 0ng 25ng Mutant 10% 25ng 2.5ng Mutant 1% 25ng 0.25ng Mutant 0% 25ng 0ng

[0122] [Table 7]

[0123] Primer sequences for simultaneous inhibition and detection

[0124] SEQ ID No. name Sequence (5'→3') 26 BJC2005-F AAGGCCTGCTGAAAATGACT 27 BJC2005-R GGTCCTGCACCAGTAATATGCA

[0125] In addition, the primers for simultaneously achieving both inhibition and detection of the K-ras gene in Table 5 were synthesized by Bioneer Co., Ltd. (Korea) (Table 7).

[0126] [Example 4]

[0127] Real-time PCR and simultaneous analysis of multiple genotypes using melting curves

[0128] 4-1: Preparation of a mixed solution of PNA probes and PCR primers for simultaneous detection of multiple somatic mutations

[0129] In order to perform simultaneous detection of multiple somatic mutations, a mixed solution of PNA probes was prepared by mixing the same amount of the PNA probe of SEQ ID No. 1 in Table 1 diluted to a concentration of 13.5 μM, the PNA probes of SEQ ID Nos. 16 to 18 diluted to a concentration of 18 μM, the PNA probe of SEQ ID No. 19 diluted to a concentration of 9 μM, the PNA probe of SEQ ID No. 20 diluted to a concentration of 18 μM, and the PNA probe of SEQ ID No. 22 diluted to a concentration of 4.5 μM. Then, the same amount of the forward primer of SEQ ID No. 26 diluted to a concentration of 1.5 μM and the reverse primer of SEQ ID No. 27 diluted to a concentration of 20 μM were mixed.

[0130] SEQ ID Nos. 15 to 19 were used as probes for mutation detection, SEQ ID No. 20 was used as an internal control, and SEQ ID No. 22 was used as a clamping probe.

[0131] By mixing the mixed solution of PNA probes and the mixed solution of primers at a ratio of 6:4, a mixed reaction solution of PNA probes and PCR primers capable of simultaneously detecting five types of somatic mutations and analyzing mutant genotypes was prepared.

[0132] 4-2: Real-time PCR and melting curve analysis for simultaneous analysis of multiple genotypes

[0133] After 10 μl of the mixed solution of the PNA probe and PCR primer prepared in Example 4-1 was mixed with 10 μl of the PCR amplification solution and 5 μl of each target nucleic acid produced in Example 3 (Table 5, Table 6) was added thereto, real-time PCR was performed (real-time PCR machine, CFX96TM Real-Time PCR System, Bio-Rad, USA). After 15 minutes of reaction at 95°C, 45 cycles were run for 10 seconds at 95°C, 7 seconds at 76°C, 20 seconds at 53°C, and 20 seconds at 72°C. Fluorescence was measured at 53°C. Then, PCR was completed by repeating 10 cycles for 10 seconds at 95°C, 7 seconds at 76°C, 20 seconds at 53°C, and 20 seconds at 72°C without measuring fluorescence. After completing the PCR cycle and performing a denaturation step at 95°C for 5 minutes, the mixture was cooled to 48°C and then hybridized for 5 minutes. Then, melting curve analysis was performed by measuring fluorescence while increasing the temperature from 48°C to 95°C in 0.5°C steps.

[0134] Figures 5 to 10 The amplification curves and melting curves obtained for each target nucleic acid are shown in Table 8. The analysis results of the melting curves of each PNA probe matching the target nucleic acid for genotyping are shown in Table 8. In addition, Fig.11 The result of merging the melting curves of G12S, G12R and G12C into a single channel is shown in .

[0135] [Table 8]

[0136] Melting curve analysis of wild-type and K-ras mutants

[0137]

[0138] As a result of analyzing the melting curves of wild-type mutations and K-ras mutations, it was found that multiple K-ras mutant genes G12A, G12S, G12R, G12C, and G13D, which are 1% of those contained in the wild-type, can be detected simultaneously.

[0139] In addition, from the amplification curve analysis of the detection probe of SEQ ID No. 20 complementary to the K-ras wild-type gene, it was confirmed that the structurally modified PNA clamp probe of the present invention could inhibit the amplification of the wild-type gene, which also supports the validity of the PCR assay.

[0140] [Example 5]

[0141] Detection of somatic mutations by MGB-taqman assay-PNA clamp

[0142] In order to confirm whether somatic mutations can be detected even when the detection probe of the present invention is a nucleic acid analog other than PNA, EGFR mutations were detected using MGB-taqman as a detection probe.

[0143] 5-1: Using somatic mutation to prepare target nucleic acid

[0144] Wild-type cell line A549 was obtained from the Korean Cell Line Bank, and EGFR-mutated cell line H1975 was obtained from ATCC to prepare target nucleic acids (Table 9).

[0145] [Table 9]

[0146] Location of EGFR mutations and mutated cell lines

[0147] Cell line name Base changes Exon mutation A549 wild type - wild type H1975 2369C>T 20 Thr790Met

[0148] The target nucleic acid was prepared and obtained in the same manner as in Example 3. The samples were prepared so that the wild-type gene included 100%, 10%, 1% or 0% of each mutant gene.

[0149] 5-2: Preparation of a mixed solution of PNA probes and PCR primers for simultaneous detection of multiple somatic mutations

[0150] Primers for mutation detection synthesized by Bioneer (Korea) (SEQ ID Nos. 28 and 29) (Table 10) and MGB-taqman probe for mutation detection synthesized by ABI (Applied Biosystems, USA) (SEQ ID No. 30) (Table 11) were used. PNA clamp probes were synthesized in the same manner as in Example 1.

[0151] [Table 10]

[0152] Base sequences of primers and MGB-taqman detection probes

[0153]

[0154] [Table 11]

[0155] Base sequence of PNA clamp probe

[0156]

[0157] In order to confirm whether the system of MGB-taqman probe for detecting mutations and PNA probe for clamping wild-type is capable of detecting and clamping different chains, real-time PCR (real-time PCR machine, CFX96TM Real-Time PCR System, Bio-Rad, USA) was performed after adding 1.6μM of forward primer (SEQ ID No.28), 0.4μM of reverse primer (SEQ ID No.29), 0.8μM of MGB-taqman probe (SEQ ID No.30), 4μM of PNA clamp probe (SEQ ID No.31), 10μl of PCR amplification solution and 5μl of each target nucleic acid generated in Example 5-1 to a total volume of 25μl.

[0158] After a reaction at 95°C for 15 minutes, 45 cycles of 10 seconds at 95°C, 20 seconds at 60°C, and 20 seconds at 72°C were repeated. Fluorescence was measured at 60°C. As a result, it was confirmed from the real-time amplification curve analysis that the system of the MGB-taqman probe for detecting mutations and the PNA probe for clamping the wild type operated on different chains. Fig.12 The results are shown in .

[0159] Probe hybrid system comprising a clamping probe and a detection probe that hybridize complementarily on the same strand

[0160] [Example 6]

[0161] Preparation of PNA probes for mutation detection and characterization

[0162] 6-1: Generation of PNA probes

[0163] In order to detect mutations using a PNA hybrid including a detection probe and a clamping probe structurally modified by changing the three-dimensional structure or imparting charges to the PNA probe and the PNA, the PNA probe was synthesized as shown in Table 12.

[0164] [Table 12]

[0165] Sequences of PNA probes used in the present invention

[0166]

[0167] (The numbers of the PNA sequences in Table 12 indicate the modification of a portion of the PNA sequence to D-glutamine. See Table 13 for more details.)

[0168] [Table 13]

[0169] Modification of PNA sequences

[0170]

[0171] As a detection probe for detecting K-ras mutant genotypes, a probe obtained by attaching a negatively charged side chain of D-glutamic acid at the γ position of the backbone of an unmodified PNA or PNA probe was used. In addition, a wild-type clamp probe was designed to bind in the same direction to enable competitive binding against the detection probe.

[0172] 6-2: Analysis of PNA probe specificity using melting curve analysis

[0173] After mixing 10 μM of PNA detection probe and 4 μM of PNA wild-type clamp probe, target DNA and PCR amplification solution (Enzynomics, Korea) and performing PCR, the binding specificity of the PNA probe sequences generated in Table 12 to the DNA target was analyzed by melting curve analysis. Real-time PCR machine (CFX96 TM Real-time PCR system, Bio-Rad, USA) was used for PCR. As a result, the probes whose melting curves were distinguished were identified according to the PNA probe sequence matching rate with the target. It was confirmed from the figure that the detection probes of SEQ ID Nos.33, 34, 37 and 38 had excellent specificity for the base sequence of the target DNA (Figure 13, Figure 14 and Figure 15). Table 14 shows an example of the Tm analysis results indicating the temperature at which the PNA probe melts from a target with a perfect matching sequence or from a target with a mismatch sequence.

[0174] [Table 14]

[0175] Comparison of single nucleotide specificity (Tm) between PNA probes and PNA probes given a three-dimensional structure

[0176]

[0177] [Example 7]

[0178] Generation of target nucleic acids and primers for detecting somatic mutations

[0179] The target nucleic acid was obtained and produced in the same manner as in Example 3. The samples were prepared so that the wild-type gene included 1%, 0.1%, 0.01% or 0% of each mutant gene (Table 15).

[0180] [Table 15]

[0181] Amount of target nucleic acid used in the reaction

[0182] wild-type gDNA Mutant gDNA Mutant 1% 25ng 250pg Mutant 0.1% 25ng 25pg Mutant 0.01% 25ng 2.5pg Mutant 0% 25ng 0ng

[0183] In addition, primers for detecting the K-ras gene in Table 15 were designed as shown in Table 16. Primers synthesized by Bioneer Co. (Korea) were used.

[0184] [Table 16]

[0185] Primer sequences used to improve detection sensitivity

[0186] SEQ ID No. name Base sequence (5'→3') 39 G12 / 13F1 AGGTACTGGTGGAGTATTTG 40 G12 / 13F2 GTGACATGTTCTAATATAGTCAC 41 G12 / 13RC1 GTTCTAAATGGAGATAACAACC 42 G12 / 13RC2 TAGCAGTTCCGTGAGAACGGATGC

[0187] [Example 8]

[0188] Improved detection sensitivity of methods for simultaneous analysis of multiple genotypes using real-time PCR and melting curve analysis

[0189] 8-1: Preparation of a mixed solution of PNA probes and PCR primers for simultaneous detection of multiple somatic mutations and Improved detection sensitivity

[0190] In order to perform simultaneous detection of multiple somatic mutations and improve the detection sensitivity thereof, a mixed solution of PNA probes was prepared by diluting the probes in Table 12 so that the PNA probe of SEQ ID No. 35 or 36 had a concentration of 4 μM, and the PNA probes of SEQ ID Nos. 32 to 34 and 37 to 38 had a concentration of 10 μM. Then, each primer was diluted so that the forward primers of SEQ ID Nos. 39 and 40 had a concentration of 3 μM, and the reverse primers of SEQ ID Nos. 41 and 42 had a concentration of 10 μM. Then, the results of each primer were observed.

[0191] The target nucleic acids generated in Table 15 were used to determine the presence of somatic mutations and measure detection sensitivity ( FIG. 13 , FIG. 14 , and FIG. 15 ).

[0192] 8-2: Measuring detection sensitivity by real-time PCR and melting curve analysis

[0193] After 10 μl of the mixed solution of the PNA probe and PCR primer prepared in 8-1 was mixed with 10 μl of PCR amplification solution (Enzynomics, South Korea), 5 μl of the prepared target DNA sample was added to perform real-time PCR (real-time PCR machine, CFX96TM real-time PCR system, Bio-Rad, USA). PCR was performed in three steps of clamping, detection and melting. After 15 minutes of reaction at 95°C, 15 cycles were run for 30 seconds at 95°C, 20 seconds at 70°C, 30 seconds at 63°C and 30 seconds at 72°C without measuring fluorescence, and 40 cycles were repeated for 10 seconds at 95°C, 20 seconds at 53°C and 20 seconds at 72°C, and fluorescence was measured at 53°C. Then, after keeping the mixture at 95°C for 15 minutes, the mixture was cooled to 35°C and hybridized for 5 minutes. Then, melting curve analysis was performed by measuring fluorescence while increasing the temperature from 35°C to 75°C in 0.5°C steps.

[0194] As a result, it was found that the melting temperature of the detection probe of SEQ ID No. 33 from the target DNA was different between G12A, G12D, G12S and G12V ( FIG. 13 (A) ). In addition, the melting temperature of the detection probe of SEQ ID No. 34 from the target DNA was different between G12A, G12D, G12S and G12V ( FIG. 13 (B) ). Therefore, it was confirmed that multiple mutant genes can be detected even with one detection probe.

[0195] That is, it was confirmed that the system in which the detection probe and the clamping probe are designed to bind to the same chain so as to react complementarily with the target is also capable of simultaneously detecting multiple K-ras mutant genes of G12A, G12D, G12V, G12S, G12R and G12C in one tube by using only two fluorescences (reporters) by utilizing the difference in the melting temperatures of the mutation detection probes.

[0196] In addition, the mutant genes (G12D, G12V) were then diluted in the obtained 25 ng of the wild-type gene (HeLa cells) so that samples were prepared to contain 1%, 0.1%, 0.01% or 0% of each mutant gene (G12D, G12V) in the wild-type gene. 4 The mutant gene of the present invention was defined as 100%. Then, PCR was performed by the above method. As a result, it was found that the amplification of the wild-type gene was suppressed by the PNA clamp probe of the present invention, and mutations contained even in an amount of 0.01% could be detected ( FIG. 14 ).

[0197] The above disclosure describes specific parts of the present invention in detail. Therefore, it is obvious to those skilled in the art that the detailed disclosure is only for exemplifying preferred embodiments, and the scope of the present invention is not limited by the disclosure. Therefore, the essential scope of the present invention is defined by the appended claims and their equivalents.

[0198] Sequence Listing Free Text

[0199] <110> PANAGENE INC.

[0200] <120> Method for detecting multiple target nucleic acids using clamping probes and detection probes

[0201] <130> F-405-PCT

[0202] <150> KR 2013-0136429

[0203] <151> 2013-11-11

[0204] <160> 42

[0205] <170> KopatentIn 2.0

[0206] <210> 1

[0207] <211> 13

[0208] <212> DNA

[0209] <213> Artificial sequence

[0210] <220>

[0211] <223> pna probe (K12-G)

[0212] <400> 1

[0213] acgccagcag ctc 13

[0214] <210> 2

[0215] <211> 13

[0216] <212> DNA

[0217] <213> Artificial sequence

[0218] <220>

[0219] <223> pna probe (K12-GL-ala)

[0220] <400> 2

[0221] acgccagcag ctc 13

[0222] <210> 3

[0223] <211> 13

[0224] <212> DNA

[0225] <213> Artificial sequence

[0226] <220>

[0227] <223> pna probe (K12-GD-ala)

[0228] <400> 3

[0229] acgccagcag ctc 13

[0230] <210> 4

[0231] <211> 13

[0232] <212> DNA

[0233] <213> Artificial sequence

[0234] <220>

[0235] <223> pna probe (K12-GL-Glu)

[0236] <400> 4

[0237] acgccagcag ctc 13

[0238] <210> 5

[0239] <211> 13

[0240] <212> DNA

[0241] <213> Artificial sequence

[0242] <220>

[0243] <223> pna probe (K12-GD-Glu)

[0244] <400> 5

[0245] acgccagcag ctc 13

[0246] <210> 6

[0247] <211> 13

[0248] <212> DNA

[0249] <213> Artificial sequence

[0250] <220>

[0251] <223> pna probe (K12-GL-Lys)

[0252] <400> 6

[0253] acgccagcag ctc 13

[0254] <210> 7

[0255] <211> 13

[0256] <212> DNA

[0257] <213> Artificial sequence

[0258] <220>

[0259] <223> pna probe (K12-GD-Lys)

[0260] <400> 7

[0261] acgccagcag ctc 13

[0262] <210> 8

[0263] <211> 13

[0264] <212> DNA

[0265] <213> Artificial sequence

[0266] <220>

[0267] <223> pna probe (K12-G-pa)

[0268] <400> 8

[0269] ctcgacgacc gca 13

[0270] <210> 9

[0271] <211> 13

[0272] <212> DNA

[0273] <213> Artificial sequence

[0274] <220>

[0275] <223> pna probe (K12-GL-ala-pa)

[0276] <400> 9

[0277] ctcgacgacc gca 13

[0278] <210> 10

[0279] <211> 13

[0280] <212> DNA

[0281] <213> Artificial sequence

[0282] <220>

[0283] <223> pna probe (K12-GD-ala-pa)

[0284] <400> 10

[0285] ctcgacgacc gca 13

[0286] <210> 11

[0287] <211> 13

[0288] <212> DNA

[0289] <213> Artificial sequence

[0290] <220>

[0291] <223> PNA probe (K12-GL-Glu-PA)

[0292] <400> 11

[0293] ctcgacgacc gca 13

[0294] <210> 12

[0295] <211> 13

[0296] <212> DNA

[0297] <213> Artificial sequence

[0298] <220>

[0299] <223> pna probe (K12-GD-Glu-pa)

[0300] <400> 12

[0301] ctcgacgacc gca 13

[0302] <210> 13

[0303] <211> 13

[0304] <212> DNA

[0305] <213> Artificial sequence

[0306] <220>

[0307] <223> pna probe (K12-GL-Lys-pa)

[0308] <400> 13

[0309] ctcgacgacc gca 13

[0310] <210> 14

[0311] <211> 13

[0312] <212> DNA

[0313] <213> Artificial sequence

[0314] <220>

[0315] <223> pna probe (K12-GD-Lys-pa)

[0316] <400> 14

[0317] ctcgacgacc gca 13

[0318] <210> 15

[0319] <211> 15

[0320] <212> DNA

[0321] <213> Artificial sequence

[0322] <220>

[0323] <223> PNA probe (SW1116-G12A-62-AP15)

[0324] <400> 15

[0325] ggagctgctg gcgta 15

[0326] <210> 16

[0327] <211> 13

[0328] <212> DNA

[0329] <213> Artificial sequence

[0330] <220>

[0331] <223> pna probe (A549-G12S-58-AP13)

[0332] <400> 16

[0333] ggagctagtg gcg 13

[0334] <210> 17

[0335] <211> 13

[0336] <212> DNA

[0337] <213> Artificial sequence

[0338] <220>

[0339] <223> pna probe (xxx-G12R-61-AP13)

[0340] <400> 17

[0341] ggagctcgtg gcg 13

[0342] <210> 18

[0343] <211> 13

[0344] <212> DNA

[0345] <213> Artificial sequence

[0346] <220>

[0347] <223> pRNA probe (MIAPaCa2-G12C-58-AP13)

[0348] <400> 18

[0349] ggagcttgtg gcg 13

[0350] <210> 19

[0351] <211> 15

[0352] <212> DNA

[0353] <213> Artificial sequence

[0354] <220>

[0355] <223> PNA probe (LoVo-G13D-61-AP15)

[0356] <400> 19

[0357] gctggtgacg taggc 15

[0358] <210> 20

[0359] <211> 13

[0360] <212> DNA

[0361] <213> Artificial sequence

[0362] <220>

[0363] <223> pna probe (internal control)

[0364] <400> 20

[0365] gcggtggtcg agg 13

[0366] <210> twenty one

[0367] <211> 17

[0368] <212> DNA

[0369] <213> Artificial sequence

[0370] <220>

[0371] <223> pna probe (K12,13CP)

[0372] <400> twenty one

[0373] cctacgccac cagctcc 17

[0374] <210> twenty two

[0375] <211> 17

[0376] <212> DNA

[0377] <213> Artificial sequence

[0378] <220>

[0379] <223> pna probe (K12,13CP glu)

[0380] <400> twenty two

[0381] cctacgccac cagctcc 17

[0382] <210> twenty three

[0383] <211> 19

[0384] <212> DNA

[0385] <213> Artificial sequence

[0386] <220>

[0387] <223> pna probe (K12down CP)

[0388] <400> twenty three

[0389] ggagctggtg gcgtaggca 19

[0390] <210> twenty four

[0391] <211> 27

[0392] <212> DNA

[0393] <213> Artificial sequence

[0394] <220>

[0395] <223> DNA oligomers (>5-up 0C)

[0396] <400> twenty four

[0397] gtagttggag ctgctggcgt aggcaag 27

[0398] <210> 25

[0399] <211> 27

[0400] <212> DNA

[0401] <213> Artificial sequence

[0402] <220>

[0403] <223> DNA oligomers (>1-up wild type)

[0404] <400> 25

[0405] gtagttggag ctggtggcgt aggcaag 27

[0406] <210> 26

[0407] <211> 20

[0408] <212> DNA

[0409] <213> Artificial sequence

[0410] <220>

[0411] <223> Primer (BJC2005-F)

[0412] <400> 26

[0413] aaggcctgct gaaaatgact 20

[0414] <210> 27

[0415] <211> twenty two

[0416] <212> DNA

[0417] <213> Artificial sequence

[0418] <220>

[0419] <223> Primer (BJC2005-R)

[0420] <400> 27

[0421] ggtcctgcac cagtaatatg ca 22

[0422] <210> 28

[0423] <211> 18

[0424] <212> DNA

[0425] <213> Artificial sequence

[0426] <220>

[0427] <223> Primer (T790M-Forward)

[0428] <400> 28

[0429] tccaccgtgc agctcatc 18

[0430] <210> 29

[0431] <211> 20

[0432] <212> DNA

[0433] <213> Artificial sequence

[0434] <220>

[0435] <223> Primer (T790M-Reverse)

[0436] <400> 29

[0437] gtctttgtgt tcccggacat 20

[0438] <210> 30

[0439] <211> 14

[0440] <212> DNA

[0441] <213> Artificial sequence

[0442] <220>

[0443] <223> T790M-Detection Probe MGB-Taqman

[0444] <400> 30

[0445] agctgcatga tgag 14

[0446] <210> 31

[0447] <211> 17

[0448] <212> DNA

[0449] <213> Artificial sequence

[0450] <220>

[0451] <223> pna probe (T790M clamping probe)

[0452] <400> 31

[0453] gctcatcacg cagctca 17

[0454] <210> 32

[0455] <211> 13

[0456] <212> DNA

[0457] <213> Artificial sequence

[0458] <220>

[0459] <223> pna probe (G12D S1)

[0460] <400> 32

[0461] gagctgatgg cgt 13

[0462] <210> 33

[0463] <211> 13

[0464] <212> DNA

[0465] <213> Artificial sequence

[0466] <220>

[0467] <223> pna probe (G12D S2)

[0468] <400> 33

[0469] gagctgatgg cgt 13

[0470] <210> 34

[0471] <211> 14

[0472] <212> DNA

[0473] <213> Artificial sequence

[0474] <220>

[0475] <223> pna probe (G12V S1)

[0476] <400> 34

[0477] ggagctgttg gcgt 14

[0478] <210> 35

[0479] <211> 17

[0480] <212> DNA

[0481] <213> Artificial sequence

[0482] <220>

[0483] <223> pna probe (K12 clamp-1)

[0484] <400> 35

[0485] atctggtggc gtaggca 17

[0486] <210> 36

[0487] <211> 15

[0488] <212> DNA

[0489] <213> Artificial sequence

[0490] <220>

[0491] <223> pna probe (K12 clamp-2)

[0492] <400> 36

[0493] ctggtggcgt aggca 15

[0494] <210> 37

[0495] <211> 11

[0496] <212> DNA

[0497] <213> Artificial sequence

[0498] <220>

[0499] <223> pna probe (G12D N2)

[0500] <400> 37

[0501] tggagctgat g 11

[0502] <210> 38

[0503] <211> 11

[0504] <212> DNA

[0505] <213> Artificial sequence

[0506] <220>

[0507] <223> pna probe (G12V N2)

[0508] <400> 38

[0509] tggagctgtt g 11

[0510] <210> 39

[0511] <211> 20

[0512] <212> DNA

[0513] <213> Artificial sequence

[0514] <220>

[0515] <223> Primer (G12 / 13F1)

[0516] <400> 39

[0517] aggtactggt ggagtatttg 20

[0518] <210> 40

[0519] <211> twenty three

[0520] <212> DNA

[0521] <213> Artificial sequence

[0522] <220>

[0523] <223> Primer (G12 / 13F2)

[0524] <400> 40

[0525] gtgacatgtt ctaatatagt cac 23

[0526] <210> 41

[0527] <211> twenty two

[0528] <212> DNA

[0529] <213> Artificial sequence

[0530] <220>

[0531] <223> Primer (G12 / 13RC1)

[0532] <400> 41

[0533] gttctaaatg gagataacaa cc 22

[0534] <210> 42

[0535] <211> twenty four

[0536] <212> DNA

[0537] <213> Artificial sequence

[0538] <220>

[0539] <223> Primer (G12 / 13RC2)

[0540] <400> 42

[0541] tagcagttcc gtgagaacgg atgc 24

Claims

1. A probe mixture for real-time detection of a target nucleic acid, the probe mixture comprising at least one detection probe and at least one clamping probe for inhibiting amplification of a wild-type gene or an unwanted gene, It is characterized in that Amino acids or side chains of amino acids are attached to the detection probe or to the detection probe and the clamping probe to structurally modify the probe so that mutations can be detected with a sensitivity of 0.01% by simultaneously analyzing the real-time amplification curve and the melting curve, The amino acid is selected from the group consisting of L-glutamic acid, D-glutamic acid, L-alanine, D-alanine, L-lysine and D-lysine.

2. The probe mixture according to claim 1, characterized in that: The detection probe or clamping probe is a nucleic acid analog selected from the group consisting of oligonucleotides, peptide nucleic acids (PNA) and locked nucleic acids (LNA).

3. The probe mixture according to claim 1, characterized in that: The amino acid is attached at the N-terminus or the C-terminus of the probe.

4. The probe mixture according to claim 1, characterized in that: The side chain of the amino acid is attached at the alpha, beta or gamma position of the probe backbone.

5. The probe mixture according to claim 1, characterized in that: A reporter and a quencher are attached to the detection probe.

6. The probe mixture according to claim 5, characterized in that: The reporter is at least one fluorescent material selected from the group consisting of fluorescein, fluorescein chlorotriazine, rhodamine green, rhodamine red, tetramethylrhodamine, FITC, Oregon Green, Alexa Fluor, FAM, JOE, ROX, HEX, Texas Red, TET, TRITC, TAMRA, cyanine-based dyes and thiodicarbonyl cyanine dyes.

7. The probe mixture according to claim 5, characterized in that: The quencher is at least one selected from the group consisting of Dabcyl, TAMRA, Eclipse, DDQ, QSY, Blackberry Quencher, Black Hole Quencher, Qxl, Iowa Black FQ, Iowa Black RQ, and IRDye QC-1.

8. A method for simultaneously detecting multiple target nucleic acids using a probe cocktail for real-time detection of target nucleic acids, the probe cocktail comprising at least one detection probe and at least one clamping probe for inhibiting amplification of a wild-type gene or an unwanted gene, It is characterized in that Amino acids or side chains of amino acids are attached to the detection probe or to the detection probe and the clamping probe to structurally modify the probe so that mutations can be detected with a sensitivity of 0.01% by simultaneously analyzing the real-time amplification curve and the melting curve, The amino acid is selected from the group consisting of L-glutamic acid, D-glutamic acid, L-alanine, D-alanine, L-lysine and D-lysine.

9. The method according to claim 8, characterized in that The detection probe or clamping probe is a nucleic acid analog selected from the group consisting of oligonucleotides, peptide nucleic acids (PNA) and locked nucleic acids (LNA).

10. The method according to claim 8, characterized in that The amino acid is attached at the N-terminus or the C-terminus of the probe.

11. The method according to claim 8, characterized in that The side chain of the amino acid is attached at the alpha, beta or gamma position of the probe backbone.

12. The method according to claim 8, characterized in that A reporter and a quencher are attached to the detection probe.

13. The method according to claim 12, characterized in that The reporter is at least one fluorescent material selected from the group consisting of fluorescein, fluorescein chlorotriazine, rhodamine green, rhodamine red, tetramethylrhodamine, FITC, Oregon Green, Alexa Fluor, FAM, JOE, ROX, HEX, Texas Red, TET, TRITC, TAMRA, cyanine-based dyes and thiodicarbonyl cyanine dyes.

14. The method according to claim 12, characterized in that The quencher is at least one selected from the group consisting of Dabcyl, TAMRA, Eclipse, DDQ, QSY, Blackberry Quencher, Black Hole Quencher, Qxl, Iowa Black FQ, Iowa Black RQ, and IRDye QC-1.

15. The method according to claim 8, characterized in that The method utilizes a clamping probe that complementarily binds to a wild-type gene to selectively amplify a target nucleic acid gene and thereby inhibits polymerase extension, and utilizes at least one detection probe for detecting a target nucleic acid to simultaneously detect the presence or concentration of multiple target nucleic acids.

16. The method according to claim 8, characterized in that The detection probe and the clamping probe bind to the same strand of the target nucleic acid strand to simultaneously perform suppression of the wild-type gene and detection of the target nucleic acid gene.

17. The method according to claim 8, characterized in that The detection probe and the clamping probe bind to different strands of the target nucleic acid strand to simultaneously perform suppression of the wild-type gene and detection of the target nucleic acid gene.

18. The method according to claim 8, characterized in that The use of a probe cocktail to detect target nucleic acids enables simultaneous analysis of real-time amplification and melting curves.

19. The method according to claim 8, characterized in that The method comprises the following steps: (a) mixing a probe mixture including a clamping probe and a detection probe and a primer with a test sample including the target nucleic acid, and hybridizing the mixture to obtain a real-time amplification curve; (b) obtaining a melting curve of the detection probe from the amplification product by changing the temperature after the amplification process; and (c) analyzing the real-time amplification curve and melting curve obtained separately, sequentially or simultaneously.

20. The method according to claim 19, characterized in that The amplification is performed by real-time polymerase chain reaction (PCR).

21. The method according to claim 19, characterized in that In addition to adding the step of obtaining a real-time amplification curve before obtaining a melting curve in (b), 5 to 20 PCR cycles are added.

22. The method according to claim 8, characterized in that The method comprises the following steps: (a) mixing a probe mixture including a clamping probe and a detection probe and a primer with a test sample including the target nucleic acid, and hybridizing the mixture to obtain a real-time amplification curve; and (b) analyzing the obtained real-time amplification curve.

23. The method according to claim 8, characterized in that The method comprises the following steps: (a) mixing a probe mixture including a clamping probe and a detection probe and a primer with a test sample including the target nucleic acid, and hybridizing the mixture; (b) melting the hybridized product by changing the temperature to obtain a melting curve; and (c) analyzing the obtained melting curve.

24. A kit for simultaneously detecting multiple target nucleic acids, the kit comprising the probe mixture according to claim 1.

Citation Information

Patent Citations

  • Methods and kits for the detection of nucleotide mutations using peptide nucleic acid as both PCR clamp and sensor probe

    US20080176226A1

  • Highly sensitive method for detecting mutated gene

    US20130005589A1

  • Highly sensitive method for detection of known variant gene and method for detection of EGFR variant gene

    JP2006288353A

  • Methods and kits for the detection of nucleotide mutations using peptide nucleic acid as both PCR clamp and sensor probe

    US7803543B2

  • KR2013-0136429